Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006.

scientific article published on 31 October 2008

Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/GUT.2008.163360
P932PMC publication ID2671084
P698PubMed publication ID18978173
P5875ResearchGate publication ID23445621

P50authorGladys BlockQ27734266
P2093author name stringP Buffler
A Kubo
T R Levin
G Rumore
D A Corley
C Quesenberry
L Habel
P2860cites workEndoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repositoryQ30969786
The changing epidemiology of esophageal cancerQ33776309
Is there publication bias in the reporting of cancer risk in Barrett's esophagus?Q33993884
Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findingsQ34037852
Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study GroupQ34059633
Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR studyQ34099177
Prevalence of Barrett's esophagus in the general population: an endoscopic studyQ34475247
Central adiposity and risk of Barrett's esophagusQ34660127
Increasing incidence of Barrett's oesophagus in the general populationQ35598185
Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopyQ37015615
Temporal changes in the endoscopic frequency of new cases of Barrett's esophagus in an Australian health region.Q40316651
New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagusQ41808634
British Society of Gastroenterology guidelines for the diagnosis of Barrett's oesophagus: are we casting the net too wide?Q42844148
Changing patterns in the incidence of esophageal and gastric carcinoma in the United StatesQ43873434
Prevalence of Barrett's esophagus in asymptomatic individualsQ44081495
Screening for Barrett's esophagus in colonoscopy patients with and without heartburnQ44184935
Rising incidence of clinically evident Barrett's oesophagus in The Netherlands: a nation-wide registry of pathology reportsQ44828036
Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents databaseQ46178134
Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomasQ46534176
Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United StatesQ46858686
Gastroesophageal reflux among different racial groups in the United StatesQ46890169
Prevalence of Barrett's esophagus in Hispanics is similar to Caucasians.Q50524288
Leptin and the risk of Barrett's oesophagus.Q50651268
Barrett's esophagus: incidence and prevalence estimates in a rural Mid-Western population.Q51109115
Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms.Q51824604
Statistical methods in cancer research. Volume IV. Descriptive epidemiologyQ52386404
Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodologyQ52861574
Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the westQ58104862
Barrett's esophagus: age, prevalence, and extent of columnar epitheliumQ67555293
Rising incidence of adenocarcinoma of the esophagus and gastric cardiaQ68199481
Barrett's esophagus: ordering the events that lead to cancerQ73133704
Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology?Q73742683
Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux diseaseQ77067422
Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United StatesQ79943821
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidenceQ81290009
Age and sex distribution of the prevalence of Barrett's esophagus found in a primary referral endoscopy centerQ81469283
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectdiagnosisQ16644043
P304page(s)182-188
P577publication date2008-10-31
P1433published inGutQ5621669
P1476titleRace, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006.
P478volume58

Reverse relations

cites work (P2860)
Q93202298A phase I pilot study evaluating the beneficial effects of black raspberries in patients with Barrett's esophagus
Q38368081A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma
Q40365358ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus
Q33618456Age- and sex-specific yield of Barrett's esophagus by endoscopy indication
Q35673305American Gastroenterological Association technical review on the management of Barrett's esophagus
Q49227522Aspirin Use is Associated With Lower Risk of Barrett’s Esophagus in Women.
Q35000054Association between obesity and Barrett's esophagus in a Japanese population: a hospital-based, cross-sectional study
Q38328606Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma
Q37591969Barrett esophagus in Asia: same disease with different pattern
Q36556299Barrett esophagus: what a mouse model can teach us about human disease
Q87451763Barrett's Esophagus
Q36014649Barrett's Esophagus: Emerging Knowledge and Management Strategies
Q26751171Barrett's esophagus in 2016: From pathophysiology to treatment
Q37861001Barrett's esophagus: a review of the literature
Q39097596Barrett's esophagus: diagnosis and management
Q45132724Barrett's esophagus: prevalence and incidence of adenocarcinomas
Q34375216Barrett's oesophagus: epidemiology, cancer risk and implications for management
Q40671403Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.
Q39614242Bile acids but not acidic acids induce Barrett's esophagus
Q37638724Bile salt receptor TGR5 is highly expressed in esophageal adenocarcinoma and precancerous lesions with significantly worse overall survival and gender differences
Q36545177Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation
Q35972032Current status and future perspectives on the etiology of esophageal adenocarcinoma
Q53038475Definition, Derivation, and Diagnosis of Barrett's Esophagus: Pathological Perspectives.
Q37055792Diagnosis and management of Barrett's esophagus
Q47662459Effects of alcohol consumption, cigarette smoking, and betel quid chewing on upper digestive diseases: a large cross-sectional study and meta-analysis
Q42843736El fenotipo de las mucinas en el esófago de Barrett: Mucin phenotypes in Barrett's esophagus
Q38374209Epidemiology and risk factors for Barrett's oesophagus
Q52615576Esophageal Motor Disorders Are a Strong and Independant Associated Factor of Barrett's Esophagus.
Q55223152Esophageal cancer incidence rates by histological type and overall: Puerto Rico versus the United States Surveillance, Epidemiology, and End Results population, 1992-2005.
Q33753299Expression of androgen receptors in Barrett esophagus.
Q51759830Gastroesophageal Reflux Frequency, Severity, Age of Onset, Family History and Acid Suppressive Therapy Predict Barrett Esophagus in a Large Population.
Q37839096Global epidemiology of Barrett's esophagus.
Q36284308High expression of Claudin-2 in esophageal carcinoma and precancerous lesions is significantly associated with the bile salt receptors VDR and TGR5.
Q35686653High expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7
Q39739602Increasing incidence of Barrett's oesophagus: a population-based study
Q38909335Influence of body mass index on the prevalence and progression of dysplasia in Barrett's esophagus: a retrospective analysis (.).
Q35979867Lamellipodin-Deficient Mice: A Model of Rectal Carcinoma
Q51155218Long-term remission of nondysplastic Barrett's esophagus after multipolar electrocoagulation ablation: report of 139 patients with 10 years of follow-up
Q38042937Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development
Q37978857MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention
Q36105522Natural history of Barrett's esophagus
Q37330745Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005
Q89285887Origins of Metaplasia in the Esophagus: Is This a GE Junction Stem Cell Disease?
Q87796763Predicting regression of Barrett's esophagus: results from a retrospective cohort of 1342 patients
Q37359638Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists
Q40083252Racial Disparity in Gastrointestinal Cancer Risk
Q53760305Racial Disparity in the Sex Distribution, the Prevalence, and the Incidence of Dysplasia in Barrett's Esophagus.
Q41444134Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort
Q28076807Risk Factors for Barrett's Oesophagus
Q36236462Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases
Q35622201Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence
Q34201351Risk factors and chemoprevention in Barrett's esophagus--an update
Q40879184Risk factors for Barrett's esophagus
Q41650709Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic Whites
Q92839270Risk factors for Barrett's esophagus in young adults who underwent upper gastrointestinal endoscopy in a health examination center
Q27002062Risk factors for neoplastic progression in Barrett's esophagus
Q41441371Risk factors of early proximal gastric carcinoma in Chinese diagnosed using WHO criteria
Q37538933Risk stratification for malignant progression in Barrett's esophagus: Gender, age, duration and year of surveillance
Q37274334Safety of endoscopic mucosal resection for Barrett's esophagus
Q30484275Secular trends in patients diagnosed with Barrett's esophagus
Q35863931Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry
Q43229859Squamous cell carcinoma in Barrett's esophagus: field effect versus metastasis
Q36832928Temporal trends of esophageal disorders by age in the Cerner Health Facts database
Q38210245The changing role of the pathologist in the management of Barrett's oesophagus
Q37677518The frequency of histologically confirmed Barrett's esophagus varies by the combination of ethnicity and gender
Q40445712The influence of Helicobacter pylori on the ethnic distribution of Barrett's metaplasia
Q51736501The metaplastic mosaic of Barrett's oesophagus.
Q39013080The natural history of gastro-esophageal reflux disease: a comprehensive review.

Search more.